CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,605,538
- in 10 filings, $6.3M under 10b5-1 plans
Net −$12,605,538. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 87 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-16 | STUELPNAGEL JOHN R Director | Sale | −300 | $199.78 | $60K | 458,491 |
| 2021-02-01 | STUELPNAGEL JOHN R Director | Sale | −400 | $174.14 | $70K | 473,091 |
| 2021-02-01 | STUELPNAGEL JOHN R Director | Sale | −3,094 | $175.38 | $543K | 469,997 |
| 2021-02-01 | STUELPNAGEL JOHN R Director | Sale | −2,304 | $176.14 | $406K | 467,693 |
| 2021-02-01 | STUELPNAGEL JOHN R Director | Sale | −1,202 | $177.23 | $213K | 466,491 |
| 2021-02-01 | STUELPNAGEL JOHN R Director | Sale | −300 | $178.16 | $53K | 466,191 |
| 2021-02-01 | STUELPNAGEL JOHN R Director | Sale | −200 | $178.98 | $36K | 465,991 |
| 2021-02-01 | Saxonov Serge Chief Executive Officer | Exercise or conversion | +9,108 | $5.04 | $46K | 889,576 |
| 2021-02-01 | Saxonov Serge Chief Executive Officer | Exercise or conversion | +892 | $11.48 | $10K | 890,468 |
| 2021-02-01 | Saxonov Serge Chief Executive Officer | Sale | −400 | $174.15 | $70K | 890,068 |
| 2021-02-01 | Saxonov Serge Chief Executive Officer | Sale | −2,575 | $175.22 | $451K | 887,493 |
| 2021-02-01 | Saxonov Serge Chief Executive Officer | Sale | −4,815 | $175.92 | $847K | 882,678 |
| 2021-02-01 | Saxonov Serge Chief Executive Officer | Sale | −1,410 | $176.99 | $250K | 881,268 |
| 2021-02-01 | Saxonov Serge Chief Executive Officer | Sale | −600 | $177.99 | $107K | 880,668 |
| 2021-02-01 | Saxonov Serge Chief Executive Officer | Sale | −200 | $178.98 | $36K | 880,468 |
| 2021-02-01 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −9,108 | 105,407 | ||
| 2021-02-01 | Saxonov Serge Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −892 | 126,671 | ||
| 2021-02-01 | McAnear Justin J. Chief Financial Officer | Exercise or conversion | +10,000 | $5.04 | $50K | 30,774 |
| 2021-02-01 | McAnear Justin J. Chief Financial Officer | Sale | −600 | $174.18 | $105K | 30,174 |
| 2021-02-01 | McAnear Justin J. Chief Financial Officer | Sale | −5,213 | $175.53 | $915K | 24,961 |
Page 47 of 57 · 1,128 trades